Repetitive transcranial magnetic stimulation-induced seizure of a patient with adolescent-onset depression: A case report and literature review

Journal of International Medical Research

Volumn 39, Issue 5, 2011, Pages 2039-2044

  Hu, S H ^a   Wang, S S ^b   Zhang, M M ^a   Wang, J W ^a   Hu, J B ^a   Huang, M L ^a   Wei, N ^a   Zhou, W H ^a   Qi, H L ^a   Xu, W J ^a   Xu, Yi ^a  

^a ZHEJIANG UNIVERSITY SCHOOL OF MEDICINE   (China)

^b Second Hospital of Ningbo   (China)

Author keywords

[No Author keywords available]

Indexed keywords

DIAZEPAM; SERTRALINE;

ADOLESCENT; ARTICLE; CHILD HEALTH CARE; CLINICAL ARTICLE; CLINICAL FEATURE; DEPRESSION; DISEASE DURATION; DOSE RESPONSE; DRUG DOSE INCREASE; DRUG EFFECT; ELECTROENCEPHALOGRAPHY; FEMALE; HUMAN; HYPOMANIA; ONSET AGE; PATIENT SAFETY; PSYCHOPHARMACOTHERAPY; REPEAT PROCEDURE; SEIZURE; TRANSCRANIAL MAGNETIC STIMULATION; TREATMENT DURATION; TREATMENT PLANNING;

EID: 80155143721     PISSN: 03000605     EISSN: None     Source Type: Journal    
DOI: 10.1177/147323001103900552     Document Type: Article

References (30)

1. Quintana H: Transcranial magnetic stimulation in persons younger than the age of 18. J ECT 2005; 21: 88-95.
2. Barker AT, Jalinous R, Freeston IL: Non-invasive magnetic stimulation of the human motor cortex. Lancet 1985; i: 1106-1107.
3. George MS, Speer AM, Molloy M, et al: Low frequency daily left prefrontal rTMS improves mood in bipolar depression: a placebocontrolled case report. Hum Psychopharmacol 1998; 13: 271-275.
4. George MS, Belmaker RH (eds): Transcranial Magnetic Stimulation in Neuropsychiatry. Washington DC: American Psychiatric Press, 2000.
5. Puri BK: The use of transcranial magnetic stimulation in major psychiatric disorders. In: The Handbook of Transcranial Magnetic Stimulation (Pascual-Leone A, ed.). London: Arnold (Hodder Headline Group), 2001; pp 359-400.
6. Martin JL, Barbanoj MJ, Schlaepfer TE, et al: Repetitive transcranial magnetic stimulation for the treatment of depression. Systematic review and meta-analysis. Br J Psychiatry 2003; 182: 480-491.
7. D'Agati D, Bloch Y, Levkovitz Y, et al: rTMS for adolescents: Safety and efficacy considerations. Psychiatry Res 2010; 177: 280-285.
8. Wassermann EM: Risk and safety of repetitive transcranial magnetic stimulation: report and suggested guidelines from the International Workshop on the Safety of Repetitive Transcranial Magnetic Stimulation, June 5-7, 1996. Electroencephalogr Clin Neurophysiol 1998; 108: 1-16.
9. Ruohonen J, Karhu J: Navigated transcranial magnetic stimulation. Neurophysiol Clin 2010; 40: 7-17.
10. Daskalakis ZJ, Christensen BK, Fitzgerald PB, et al: Transcranial magnetic stimulation: a new investigational and treatment tool in psychiatry. J Neuropsychiatry Clin Neurosci 2002; 14: 406-415.
11. Rossi S, Hallett M, Rossini PM, et al: Safety, ethical considerations, and application guidelines for the use of transcranial magnetic stimulation in clinical practice and research. Clin Neurophysiol 2009; 120: 2008-2039.
12. Loo CK, McFarquhar TF, Mitchell PB: A review of the safety of repetitive transcranial magnetic stimulation as a clinical treatment for depression. Int J Neuropsychopharmacol 2008; 11: 131-147.
13. O'Reardon JP, Solvason HB, Janicak PG, et al: Efficacy and safety of transcranial magnetic stimulation in the acute treatment of major depression: a multisite randomized controlled trial. Biol Psychiatry 2007; 62: 1208-1216.
14. March J, Silva S, Petrycki S, et al: Fluoxetine, cognitive-behavioral therapy and their combination for adolescents with depression: Treatment for Adolescents With Depression Study (TADS) randomized controlled trial. JAMA 2004; 292: 807-820.
15. Brent D, Emslie G, Clarke G, et al: Switching to another SSRI or to venlafaxine with or without cognitive behavioral therapy for adolescents with SSRI-resistant depression: the TORDIA randomized controlled trial. JAMA 2008; 299: 901-913.
16. Ustün TB, Goldberg D, Cooper J, et al: New classification for mental disorder with management guidelines for use in primary care: ICD-10 PHC chapter five. Br J Gen Pract 1995; 45: 211-215.
17. Pascual-Leone A, Rubio B, Pallardó F, et al: Rapid-rate transcranial magnetic stimulation of left dorsolateral prefrontal cortex in drugresistant depression. Lancet 1996; 348: 233-237.
18. Pascual-Leone A, Davey NJ, Rothwell J, et al (eds): Handbook of Transcranial Magnetic Stimulation. New York: Oxford University Press, 2002.
19. Dhuna A, Gates J, Pascual-Leone A: Transcranial magnetic stimulation in patients with epilepsy. Neurology 1991; 41: 1067-1071.
20. Hufnagel A, Elger CE: Induction of seizures by transcranial magnetic stimulation in epileptic patients. J Neurol 1991; 238: 109-110.
21. Kandler R: Safety of transcranial magnetic stimulation. Lancet 1990; 335: 469-470.
22. Pisani F, Oteri G, Costa C, et al: Effects of psychotropic drugs on seizure threshold. Drug Saf 2002; 25: 91-110.
23. Rossini PM, Desiato MT, Caramia MD: Agerelated changes of motor evoked potentials in healthy humans: non-invasive evaluation of central and peripheral motor tracts excitability and conductivity. Brain Res 1992; 593: 14-19.
24. Hauser WA, Kurland LT: The epidemiology of epilepsy in Rochester, Minnesota, 1935 through 1967. Epilepsia 1975; 16: 1-66.
25. Thomé-Souza MS, Kuczynski E, Valente KD: Sertraline and fluoxetine: safe treatments for children and adolescents with epilepsy and depression. Epilepsy Behav 2007; 10: 417-425.
26. Haddad PM, Dursun SM: Neurological complications of psychiatric drugs: clinical features and management. Hum Psychopharmacol 2008; 23(suppl 1): 15-26.
27. Spigset O: Adverse reactions of selective serotonin reuptake inhibitors: reports from a spontaneous reporting system. Drug Saf 1999; 20: 277-287.
28. Nedjat S, Folkerts HW: Induction of a reversible state of hypomania by rapid-rate transcranial magnetic stimulation over the left prefrontal lobe. J ECT 1999; 15: 166-168.
29. Angst J, Angst K, Baruffol I, et al: ECT-induced and drug-induced hypomania. Convuls Ther 1992; 8: 179-185.
30. Michael N, Erfurth A: Treatment of bipolar mania with right prefrontal rapid transcranial magnetic stimulation. J Affect Disord 2004; 78: 253-257.